Skip to main content
. 2017 Dec 17;9(3):3779–3793. doi: 10.18632/oncotarget.23375

Figure 5. The ATM R32C mutant allele found in MMC-resistant individuals is dispensable for the enhanced survival.

Figure 5

(A) Sanger sequencing showing a heterozygous 94C>T mutation in the ATM gene for the mother, P1 and its sister. (B) CRISPR-Cas9 target sequence in exon 3 of human ATM. (C) MMC survival of a healthy control, the father, the mother and clones #1, 2,11 and 14. Results shown as mean ± SD of duplicates are representative of 3 independent experiments.